A randomized phase 2 study of MK-2206 versus everolimus in refractory renal cell carcinoma

E. Jonasch, E. Hasanov, P. G. Corn, T. Moss, K. R. Shaw, S. Stovall, V. Marcott, B. Gan, S. Bird, X. Wang, K. A. Do, P. F. Altamirano, A. J. Zurita, L. A. Doyle, Primo N Lara, N. M. Tannir

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'A randomized phase 2 study of MK-2206 versus everolimus in refractory renal cell carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences